Literature DB >> 9012818

Activation of human B-MYB by cyclins.

A Sala1, M Kundu, I Casella, A Engelhard, B Calabretta, L Grasso, M G Paggi, A Giordano, R J Watson, K Khalili, C Peschle.   

Abstract

B-MYB expression is associated with cell proliferation and recent studies have suggested that it promotes the S phase of mammalian cells. Based on its homology to the transcription factors c-MYB and A-MYB, B-MYB is thought to be involved in transcriptional regulation; however, its activity is not detectable in several cell lines. It was postulated that B-MYB function may depend on the presence of a cofactor, and recent studies suggested that B-MYB is phosphorylated specifically during S phase in murine fibroblasts. In this report we provide evidence that the product of the human B-myb gene can be activated in vivo by coexpression with cyclin A or cyclin E. Transfection studies showed that B-MYB was a weak transcriptional activator in SAOS-2 cells and was unable to promote their proliferation. In contrast, overexpression of both B-MYB and cyclin A or cyclin E caused a drastic increase in the number of SAOS-2 cells in S phase. Also, overexpression of cyclin A and cyclin E in SAOS-2 cells enhanced the ability of B-MYB, but not c-MYB, to transactivate various promoters, including the cdc2 promoter, the HIV-1-LTR, and the simian virus 40 minimal promoter. A direct role for cyclin-dependent activation of B-MYB was demonstrated using an in vitro transcription assay. These observations suggest that one mechanism by which cyclin A and E may promote the S phase is through modification and activation of B-MYB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012818      PMCID: PMC19547          DOI: 10.1073/pnas.94.2.532

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.

Authors:  A Sala; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.

Authors:  M Arsura; M Introna; F Passerini; A Mantovani; J Golay
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

3.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

Review 4.  The role of Myb proteins in normal and neoplastic cell proliferation.

Authors:  J Lyon; C Robinson; R Watson
Journal:  Crit Rev Oncog       Date:  1994

5.  Functional domains of the human B-myb gene product.

Authors:  H Nakagoshi; Y Takemoto; S Ishii
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

6.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase.

Authors:  D G Johnson; J K Schwarz; W D Cress; J R Nevins
Journal:  Nature       Date:  1993-09-23       Impact factor: 49.962

7.  c-myb transactivates cdc2 expression via Myb binding sites in the 5'-flanking region of the human cdc2 gene.

Authors:  D H Ku; S C Wen; A Engelhard; N C Nicolaides; K E Lipson; T A Marino; B Calabretta
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

8.  Characterization and cell cycle-regulated expression of mouse B-myb.

Authors:  E W Lam; C Robinson; R J Watson
Journal:  Oncogene       Date:  1992-09       Impact factor: 9.867

9.  TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.

Authors:  G Foos; S Natour; K H Klempnauer
Journal:  Oncogene       Date:  1993-07       Impact factor: 9.867

10.  Functional antagonism between members of the myb family: B-myb inhibits v-myb-induced gene activation.

Authors:  G Foos; S Grimm; K H Klempnauer
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  30 in total

1.  The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.

Authors:  Xiaolin Li; Donald P McDonnell
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Regulation of a Myb transcription factor by cyclin-dependent kinase 2 in Giardia lamblia.

Authors:  Chao-Cheng Cho; Li-Hsin Su; Yu-Chang Huang; Yu-Jiao Pan; Chin-Hung Sun
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

3.  The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression.

Authors:  Subhashini Sadasivam; Shenghua Duan; James A DeCaprio
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

Review 4.  Conservation and diversification of three-repeat Myb transcription factors in plants.

Authors:  Masaki Ito
Journal:  J Plant Res       Date:  2005-02-10       Impact factor: 2.629

5.  Aberrant expression of cyclin D1 in cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Sign Transduct Insights       Date:  2015-09-20

6.  Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription.

Authors:  P Fojas de Borja; N K Collins; P Du; J Azizkhan-Clifford; M Mudryj
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

7.  B-myb is a gene implicated in cell cycle and proliferation of breast cancer.

Authors:  Deyou Tao; Yihong Pan; Hongsheng Lu; Song Zheng; Hui Lin; Hongyan Fang; Feilin Cao
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

8.  Arabidopsis TSO1 and MYB3R1 form a regulatory module to coordinate cell proliferation with differentiation in shoot and root.

Authors:  Wanpeng Wang; Paja Sijacic; Pengbo Xu; Hongli Lian; Zhongchi Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-13       Impact factor: 11.205

9.  B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1).

Authors:  Eugen Werwein; Thore Schmedt; Heiko Hoffmann; Clemens Usadel; Nora Obermann; Jeffrey D Singer; Karl-Heinz Klempnauer
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

10.  Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.

Authors:  Lisa K Pierson-Mullany; Carol A Lange
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.